Urinary chemerin as a potential biomarker for inflammatory bowel disease

Urinary chemerin as a potential biomarker for inflammatory bowel disease

PurposeSystemic levels of the adipokine chemerin are elevated in different inflammatory conditions such as inflammatory bowel disease (IBD). In IBD, chemerin protein expression in colon mucosa is induced and serum chemerin levels are increased. Aim of this study was to identify chemerin protein in h...

Full description

Bibliographic Details
Main Authors:	Stefan Gunawan, Tanja Elger, Johanna Loibl, Tanja Fererberger, Stefanie Sommersberger, Arne Kandulski, Martina Müller, Hauke Christian Tews, Christa Buechler
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Medicine
Subjects:	urine biomarker feces calprotectin creatinine C-reactive protein Crohn’s disease
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2022.1058108/full

Similar Items

Fecal short chain fatty acids and urinary 3-indoxyl sulfate do not discriminate between patients with Crohn´s disease and ulcerative colitis and are not of diagnostic utility for predicting disease severity
by: Hauke Christian Tews, et al.
Published: (2023-10-01)

Altered fecal bile acid composition in active ulcerative colitis
by: Stefanie Sommersberger, et al.
Published: (2023-11-01)

Urinary Hydroxyproline as an Inflammation-Independent Biomarker of Inflammatory Bowel Disease
by: Muriel Huss, et al.
Published: (2024-06-01)

Fecal Nervonic Acid as a Biomarker for Diagnosing and Monitoring Inflammatory Bowel Disease
by: Claudia Kunst, et al.
Published: (2024-12-01)

Fistulising skin metastases in Crohn’s disease: a case report and review of the literature
by: Tanja Elger, et al.
Published: (2024-05-01)

Inflammatory bowel disease increases the levels of albuminuria and the risk of urolithiasis: a two-sample Mendelian randomization study
by: Hao Wu, et al.
Published: (2023-05-01)

Kinetics of 15 per- and polyfluoroalkyl substances (PFAS) after single oral application as a mixture – A pilot investigation in a male volunteer
by: Klaus Abraham, et al.
Published: (2024-11-01)

Fecal calprotectin in inflammatory bowel disease
by: Walsham NE, et al.
Published: (2016-01-01)

Urinary prostaglandin metabolites evaluation for activity monitoring in inflammatory bowel disease
by: Renata d’Inca, et al.
Published: (2025-01-01)

Fecal calprotectin from ileostomy output in patients with Crohn’s disease
by: Jung-Bin Park, et al.
Published: (2025-02-01)

Fecal Calprotectin at Postinduction Is Capable of Predicting Persistent Remission and Endoscopic Healing after 1 Year of Treatment with Infliximab in Pediatric Patients with Crohn’s Disease
by: Yoo Min Lee, et al.
Published: (2024-05-01)

STUDY OF ALBUMIN, C-REACTIVE PROTEIN AND CALPROTECTIN AS NON-INVASIVE INDICATORS FOR THE DIAGNOSIS AND DIFFERENTIATION OF INFLAMMATORY BOWEL DISEASE
by: Aamer M. Ali, et al.
Published: (2024-04-01)

A Correlation between First-void Morning Urinary Protein to Creatinine Ratio (UPCR) and 24 Hours Urinary Protein in Pregnancy with Suspected Preeclampsia
by: Pimchanok Pariyaeksut, et al.
Published: (2014-12-01)

The Role of Small-Bowel Capsule Endoscopy in the Diagnostic Algorithm of Complicated Perianal Disease
by: Irit Avni-Biron, et al.
Published: (2024-08-01)

Urinary creatinine concentration and urine color as indicators of specimen validity test
by: Jaehyeong Park, et al.
Published: (2023-09-01)

Fecal and Urinary Adipokines as Disease Biomarkers
by: Hauke C. Tews, et al.
Published: (2023-04-01)

Semiochemicals from Domestic Cat Urine and Feces Reduce Use of Scratching Surfaces
by: Lingna Zhang, et al.
Published: (2024-02-01)

Non-Invasive Measurement of Thyroid Hormones in Domestic Rabbits
by: Maria Chmurska-Gąsowska, et al.
Published: (2021-04-01)

Evaluasi Kesehatan Sapi Perah
by: Reni Ita Safitri, et al.
Published: (2015-10-01)

Predictive value of tissue calprotectin for disease recurrence after ileocecal resection in pediatric Crohn's disease
by: Kristyna Zarubova, et al.
Published: (2022-09-01)

Diagnostic Accuracy of Fecal Calprotectin for the Detection of Small Bowel Crohn’s Disease through Capsule Endoscopy: An Updated Meta-Analysis and Systematic Review
by: Eun Suk Jung, et al.
Published: (2021-09-01)

Evaluation of protocols to determine urine output and urinary urea nitrogen excretion in dairy cows with and without dietary salt supplementation
by: P. Letelier, et al.
Published: (2024-09-01)

Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?
by: Jun Kato, et al.
Published: (2016-01-01)

Spot Urine Albumin to Creatinine Ratio versus Urine Protein to Creatinine Ratio for the Diagnosis of Proteinuria in Pregnancy
by: Paroon Sanoonrat, et al.
Published: (2017-12-01)

Evaluation of Urinary Neutrophil Gelatinase Associated Lipocalin and Kidney Injury Molecule-1 as Diagnostic Markers for Early Nephropathy in Patients with Type 2 Diabetes Mellitus
by: Quang TH, et al.
Published: (2020-06-01)

The Common and Unique Pattern of Microbiome Profiles among Saliva, Tissue, and Stool Samples in Patients with Crohn’s Disease
by: Seung Yong Shin, et al.
Published: (2022-07-01)

Faecal calprotectin – a useful tool in the management of inflammatory bowel disease
by: Emanuel Burri, et al.
Published: (2012-03-01)

Comparison of 24-hour urinary protein and protein-to-creatinine ratio in the assessment of proteinuria
by: Wahbeh Ayman, et al.
Published: (2009-01-01)

Relationship between Urine Creatinine and Urine Osmolality in Spot Samples among Men and Women in the Danish Diet Cancer and Health Cohort
by: Selinay Ozdemir, et al.
Published: (2021-11-01)

Isolation of Methicillin Resistant Staphylococcus aureus (MRSA) from Rattus rattus from Adhamiyah district in Baghdad governorate
by: Sahar K. Khalaf, et al.
Published: (2015-11-01)

Correlation of spot urinary protein: Creatinine ratio and quantitative proteinuria in pediatric patients with nephrotic syndrome
by: Richa Singh, et al.
Published: (2019-01-01)

Inflammation and tissue remodeling contribute to fibrogenesis in stricturing Crohn’s disease: image processing and analysis study
by: Mustafa Erdem Arslan, et al.
Published: (2022-09-01)

Fecal S100A12 is associated with future hospitalization and step-up of medical treatment in patients with Crohn’s disease in clinical remission: a pilot study
by: Sun-Ho Lee, et al.
Published: (2022-04-01)

Fecal Calprotectin in Patients with Crohn’s Disease: A Study Based on the History of Bowel Resection and Location of Disease
by: Jeongkuk Seo, et al.
Published: (2024-04-01)

Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults
by: Małgorzata Krzystek-Korpacka, et al.
Published: (2020-06-01)

What Happens to Patients with Inflammatory Bowel Disease Who Are Intolerant to Thiopurines?
by: Helena Gensmyr-Singer, et al.
Published: (2024-06-01)

Usefulness of fecal calprotectin by monoclonal antibody testing in adult Japanese with inflammatory bowel diseases: a prospective multicenter study
by: Shiro Nakamura, et al.
Published: (2018-10-01)

Assessment of urinary podocalyxin as a biomarker of early diagnosis of hypertensive nephropathy
by: I. Kostovska, et al.
Published: (2023-10-01)

Serum calprotectin is useful to confirm inflammatory bowel disease activity but not to predict relapse
by: Pauline Veyrard, et al.
Published: (2022-12-01)

Inflammatory Bowel Diseases in Children: Modern Achievements in Diagnostics and Therapy
by: A. I. Khavkin, et al.
Published: (2024-01-01)